Article

Divide et Impera: An In Silico Screening Targeting HCMV ppUL44 Processivity Factor Homodimerization Identifies Small Molecules Inhibiting Viral Replication

2020-11-23

Abstract excerpt

Human cytomegalovirus (HCMV) is a leading cause of severe diseases in immunocompromised individuals, including AIDS and transplanted patients, and in congenitally infected newborns. The utility of available drugs is limited by poor bioavailability, toxicity, and emergence of resistant strains. Therefore, it is crucial to identify new targets of therapeutic intervention. Among the latter, viral protein-protein inte...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d0783416-fa7b-5241-bb81-4dd873967494
DOI: 10.20944/preprints202011.0560.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Divide et Impera: An In Silico Screening Targeting HCMV ppUL44 Processivity Factor Homodimerization Identifies Small Molecules Inhibiting Viral ReplicationDOI 10.20944/preprints202011.0560.v1Read

Divide et Impera: Identification of Small-Molecule Inhibitors of HCMV Replication Interfering with Dimerization of DNA Polymerase Processivity Factor UL44Semantic proximity Read

Phenotypic Screening Identifies Small-Molecule Inhibitors with Distinct Activities across the BK Polyomavirus Life CycleSemantic proximity Read

Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of actionSemantic proximity Read

Deciphering letermovir's mode of action and resistance mutation effects.Semantic proximity Read

The human cytomegalovirus terminase complex as an antiviral target: a close-up viewSemantic proximity Read

The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral TerminaseSemantic proximity Read

DNA encapsidation as a target for anti-herpesvirus drug therapy.Semantic proximity Read

Generation of a panel of mutants that are resistant to standard of care therapies in a clinically relevant strain of human cytomegalovirus for drug resistance profiling.Semantic proximity Read

New small-molecule inhibitors effectively blocking picornavirus replication.Semantic proximity Read

The Human Cytomegalovirus Trimer and Pentamer Promote Sequential Steps in Entry into Epithelial and Endothelial Cells at Cell Surfaces and EndosomesSemantic proximity Read

Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus ReplicationSemantic proximity Read

Human Cytomegalovirus UL78 is a Nuclear-Localized GPCR Necessary for Efficient Reactivation from Latent Infection in CD34 <sup>+</sup> Hematopoietic Progenitor CellsSemantic proximity Read